arrow back backwards u-turn turn around reverse
Pharma

Hims quits on obesity pill after legal, regulatory heat

Hims has quickly retreated from its launch of a compounded obesity pill after facing mounting pressure from the FDA and Novo Nordisk.
Fraiser Kansteiner Feb 9, 2026 10:24am
Narasimhan

Novartis CEO pay soars 30% to $32M in 2025

Feb 9, 2026 3:54pm
Community oncologys growing role in the future of cancer care

Community oncology’s growing role in the future of cancer care

Feb 9, 2026 8:00am
AI
Favicon Fierce Biotech

BMS and Evinova pen global development partnership

Feb 9, 2026 2:33pm
Food and Drug Administration

Regulatory tracker: Scotland issues 2nd thumbs down to Kisunla

Feb 9, 2026 1:00pm
Otsuka

Otsuka awareness campaign urges HCPs to see ‘All of ADHD’

Feb 9, 2026 12:22pm
More News

Fresenius, Phlow link up to boost US epinephrine injection supply

Feb 9, 2026 11:08am

Editor’s Corner: Pharma's slack tightening across pipelines, trust

Feb 9, 2026 3:00am

Lilly lauds scientific, athletic progress in Winter Olympics ad

Feb 6, 2026 5:00pm
Fierce Biotech

Genentech cut at least 489 jobs last year, new filing reveals

Feb 6, 2026 1:38pm